Clinical Trial

Study of Melanoma-Resistant PET Monitoring Based on Key Rate-limiting Enzymes for Fatty Acid Metabolism in Healthy Volunteers

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 11, 2025 (before its estimated October 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a small-sample safety study involving 15 healthy volunteers who were divided into groups and underwent 68Ga-ACC-DE, 68Ga-FASN-DE, and 68Ga-ACLY-DE PET/CT imaging for safety, biodistribution, and radiation dosimetry assessments, laying the foundation for subsequent studies on the efficacy of resistance monitoring in melanoma targeted therapy.
Trial Details
NCT Number NCT07114172
Lead Sponsor Xijing Hospital
Conditions Melanoma (Skin Cancer), Health Volunteers, PET / CT
Enrollment 15 participants
Start Date 2025-08-15
Primary Completion 2025-10-15 (estimated)
Study Completion 2025-10-15 (estimated)
Updated on ClinicalTrials.gov 2025-08-11